









市場行情
/
股票
/
nasdaq-atrc
/

AtriCure Inc

ATRC

40.330USD

-0.220-0.54%

收盤 12/26, 16:00（美東）報價延遲15分鐘

2.00B總市值

虧損本益比TTM



AtriCure Inc

40.330

-0.220-0.54%

概覽公司財務分析

概覽

公司

財務

分析

關於 AtriCure Inc 公司

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Inc簡介



公司代碼ATRC

公司名稱AtriCure Inc

上市日期Aug 05, 2005

CEOCarrel (Michael H)

員工數量1300

證券類型Ordinary Share

年結日Aug 05

公司地址7555 Innovation Way

城市MASON

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編45040

電話15137554100

網址https://www.atricure.com

公司代碼ATRC

上市日期Aug 05, 2005

CEOCarrel (Michael H)

AtriCure Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

702.94K

-0.85%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

78.80K

-6.15%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

71.87K

-3.36%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

Mr. Sven A. Wehrwein, CPA

Independent Director

34.37K

Ms. Regina E. (Reggie) Groves

Independent Director

33.72K

-6.78%

Ms. Deborah H. (Deb) Telman

Independent Director

22.18K

+32.18%

Mr. Shlomo Nachman

Independent Director

18.51K

+41.20%

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

702.94K

-0.85%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

78.80K

-6.15%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

71.87K

-3.36%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

United States

110.58M

81.23%

Europe

16.13M

11.85%

Asia

7.48M

5.50%

Other international

1.94M

1.42%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月15日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.71%

Wellington Management Company, LLP

8.63%

AllianceBernstein L.P.

7.16%

BlackRock Institutional Trust Company, N.A.

6.86%

Hood River Capital Management LLC

6.13%

其他

61.50%

持股股東

佔比

The Vanguard Group, Inc.

9.71%

Wellington Management Company, LLP

8.63%

AllianceBernstein L.P.

7.16%

BlackRock Institutional Trust Company, N.A.

6.86%

Hood River Capital Management LLC

6.13%

其他

61.50%

股東類型

持股股東

佔比

Investment Advisor

51.23%

Investment Advisor/Hedge Fund

39.51%

Hedge Fund

5.89%

Individual Investor

3.47%

Research Firm

1.65%

Pension Fund

0.79%

Bank and Trust

0.54%

Family Office

0.07%

Insurance Company

0.03%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

492

49.59M

116.79%

-102.71K

2025Q3

520

49.71M

119.25%

-705.98K

2025Q2

524

50.25M

121.23%

-1.55M

2025Q1

527

51.69M

113.33%

-4.41M

2024Q4

514

47.94M

122.38%

-3.05M

2024Q3

505

52.36M

125.18%

-207.95K

2024Q2

494

52.59M

116.92%

+1.07M

2024Q1

500

51.55M

109.93%

-1.63M

2023Q4

498

48.92M

106.78%

+1.54M

2023Q3

486

47.46M

108.31%

+99.25K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

4.90M

9.85%

+191.85K

+4.08%

Jun 30, 2025

Wellington Management Company, LLP

3.97M

7.99%

+3.27M

+465.38%

Jun 30, 2025

AllianceBernstein L.P.

3.57M

7.19%

-103.20K

-2.81%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

3.45M

6.94%

-124.60K

-3.49%

Jun 30, 2025

Hood River Capital Management LLC

3.06M

6.16%

+61.85K

+2.06%

Jun 30, 2025

Nomura Investment Management Business Trust

2.50M

5.04%

+66.37K

+2.72%

Jun 30, 2025

Champlain Investment Partners, LLC

2.02M

4.06%

-121.21K

-5.67%

Jun 30, 2025

State Street Investment Management (US)

1.27M

2.56%

-4.56K

-0.36%

Jun 30, 2025

Neuberger Berman, LLC

1.19M

2.39%

+3.67K

+0.31%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.18M

2.38%

+14.58K

+1.25%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

State Street SPDR S&P Health Care Equipment ETF

1.75%

Harbor Human Capital Factor US Small Cap ETF

0.7%

Invesco NASDAQ Future Gen 200 ETF

0.5%

First Trust Small Cap Growth AlphaDEX Fund

0.44%

Fidelity Enhanced Small Cap ETF

0.33%

Amplify Etho Climate Leadership U.S. ETF

0.3%

Franklin US Small Cap Multifactor Index ETF

0.25%

JPMorgan Fundamental Data Science Small Core ETF

0.24%

iShares U.S. Medical Devices ETF

0.2%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.17%

State Street SPDR S&P Health Care Equipment ETF

佔比1.75%

Harbor Human Capital Factor US Small Cap ETF

佔比0.7%

Invesco NASDAQ Future Gen 200 ETF

佔比0.5%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.44%

Fidelity Enhanced Small Cap ETF

佔比0.33%

Amplify Etho Climate Leadership U.S. ETF

佔比0.3%

Franklin US Small Cap Multifactor Index ETF

佔比0.25%

JPMorgan Fundamental Data Science Small Core ETF

佔比0.24%

iShares U.S. Medical Devices ETF

佔比0.2%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.17%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

AtriCure Inc的前五大股東是誰？



AtriCure Inc的前五大股東如下：
The Vanguard Group, Inc.
持有股份：4.90M
佔總股份比例：9.85%。
Wellington Management Company, LLP
持有股份：3.97M
佔總股份比例：7.99%。
AllianceBernstein L.P.
持有股份：3.57M
佔總股份比例：7.19%。
BlackRock Institutional Trust Company, N.A.
持有股份：3.45M
佔總股份比例：6.94%。
Hood River Capital Management LLC
持有股份：3.06M
佔總股份比例：6.16%。